Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis.
Dwabe S, Hsiao M, Ali A, Rodman J, Savitala-Damerla L, Nazaretyan S, Kimberly Schiff NP, Tam E, Ladha A, Woan K, Chaudhary P, Yaghmour G. Dwabe S, et al. Among authors: ali a. Transpl Immunol. 2023 Feb;76:101769. doi: 10.1016/j.trim.2022.101769. Epub 2022 Dec 2. Transpl Immunol. 2023. PMID: 36464218
Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study.
Ashouri K, Nittur V, Ginosyan AA, Hwang J, Adnani B, Chen D, Savitala-Damerla L, Schiff K, Chaudhary P, Kovach AE, Ladha A, Siddiqi I, Ali A, Woan K, Tam E, Yaghmour G. Ashouri K, et al. Among authors: ali a. Clin Lymphoma Myeloma Leuk. 2024 Mar;24(3):e59-e66.e2. doi: 10.1016/j.clml.2023.11.002. Epub 2023 Nov 19. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38061959
Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study.
Ashouri K, Ginosyan AA, Chu M, Hom B, Hwang J, Resnick K, Rahimi Y, Chaudhary P, Woan K, Siddiqi I, Ladha A, Ali A, Tam EL, Yaghmour G. Ashouri K, et al. Among authors: ali a. Leuk Res. 2024 Jun;141:107501. doi: 10.1016/j.leukres.2024.107501. Epub 2024 Apr 12. Leuk Res. 2024. PMID: 38631149
Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.
Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan AA, Tam E, Ladha A, Woan K, Chaudhary P, Siddiqi I, Yaghmour G. Ashouri K, et al. Among authors: ali a. EJHaem. 2024 Apr 8;5(2):423-427. doi: 10.1002/jha2.885. eCollection 2024 Apr. EJHaem. 2024. PMID: 38633126 Free PMC article. No abstract available.
Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus.
Ashouri K, Fernandez E, Ginosyan A, Feliciano CM, Hom B, Rodman J, Ali A, Ladha A, Woan K, Tam E, Chaudhary P, Yaghmour G. Ashouri K, et al. Among authors: ali a. Transplant Proc. 2024 Sep;56(7):1671-1677. doi: 10.1016/j.transproceed.2024.08.004. Epub 2024 Aug 22. Transplant Proc. 2024. PMID: 39174390
Combination Therapy With Asciminib and Ponatinib as a Bridge to Brexucabtagene Autoleucel and Maintenance in a Patient With Relapsed Refractory Philadelphia Positive B-Cell Acute Lymphoblastic Leukemia.
Amin Muhammad A, Mir Ghazi E, Ali A, Tam E, Woan K, Chaudhary P, Yaghmour G, Ladha A. Amin Muhammad A, et al. Among authors: ali a. J Med Cases. 2024 Oct;15(10):261-266. doi: 10.14740/jmc4287. Epub 2024 Sep 20. J Med Cases. 2024. PMID: 39328803 Free PMC article.
12,322 results
You have reached the last available page of results. Please see the User Guide for more information.